Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic value of p53 molecular status in high-risk primary breast cancer.
Marchetti P, Cannita K, Ricevuto E, De Galitiis F, Di Rocco ZC, Tessitore A, Bisegna R, Porzio G, De Rubeis GP, Ventura T, Martinotti S, Ficorella C. Marchetti P, et al. Among authors: bisegna r. Ann Oncol. 2003 May;14(5):704-8. doi: 10.1093/annonc/mdg197. Ann Oncol. 2003. PMID: 12702523 Free article.
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?].
Ricevuto E, Marchetti P, Cannita K, De Galitiis F, Di Rocco ZC, Tessitore A, Martella F, Bisegna R, Porzio G, Bafile A, Vicentini R, Resta V, Mattucci S, Ventura T, Martinotti S, de Rubeis GP, Ficorella C. Ricevuto E, et al. Among authors: bisegna r. Tumori. 2003 Jul-Aug;89(4 Suppl):197-9. Tumori. 2003. PMID: 12903592 Review. Italian.
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach].
Ricevuto E, Di Rocco ZC, Cianci G, Bisegna R, Casilli F, De Galitiis F, Cannita K, Calista F, Porzio G, Bafile A, Vicentini R, Resta V, De Rubeis G, Martinotti S, Ficorella C, Marchetti P. Ricevuto E, et al. Among authors: bisegna r. Suppl Tumori. 2002 May-Jun;1(3):S89-91. Suppl Tumori. 2002. PMID: 12415797 Review. Italian. No abstract available.
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation.
Aretini P, D'Andrea E, Pasini B, Viel A, Mariani Costantini R, Cortesi L, Ricevuto E, Agata S, Bisegna R, Boiocchi M, Caligo MA, Chieco-Bianchi L, Cipollini G, Crucianelli R, D'Amico C, Federico M, Ghimenti C, De Giacomi C, De Nicolo A, Della Puppa L, Ferrari S, Ficorella C, Iandolo D, Manoukian S, Marchetti P, Marroni F, Menin C, Montagna M, Ottini L, Pensotti V, Pierotti M, Radice P, Santarosa M, Silingardi V, Turchetti D, Bevilacqua G, Presciuttini S. Aretini P, et al. Among authors: bisegna r. Breast Cancer Res Treat. 2003 Sep;81(1):71-9. doi: 10.1023/a:1025428807472. Breast Cancer Res Treat. 2003. PMID: 14531499
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations.
Marroni F, Aretini P, D'Andrea E, Caligo MA, Cortesi L, Viel A, Ricevuto E, Montagna M, Cipollini G, Ferrari S, Santarosa M, Bisegna R, Bailey-Wilson JE, Bevilacqua G, Parmigiani G, Presciuttini S. Marroni F, et al. Among authors: bisegna r. J Med Genet. 2004 Apr;41(4):278-85. doi: 10.1136/jmg.2003.013623. J Med Genet. 2004. PMID: 15060102 Free PMC article. No abstract available.
Maintenance immunotherapy in metastatic breast cancer.
Recchia F, Sica G, Candeloro G, Necozione S, Bisegna R, Bratta M, Rea S. Recchia F, et al. Among authors: bisegna r. Oncol Rep. 2008 Nov;20(5):1173-9. Oncol Rep. 2008. PMID: 18949418 Clinical Trial.
14 results